Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer

A. B. Schrock, C. Ouyang, J. Sandhu, E. Sokol, D. Jin, J. S. Ross, V. A. Miller, D. Lim, I. Amanam, J. Chao, D. Catenacci, M. Cho, F. Braiteh, S. J. Klempner, S. M. Ali, M. Fakih

    Research output: Contribution to journalArticlepeer-review

    56 Scopus citations

    Fingerprint Dive into the research topics of 'Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer'. Together they form a unique fingerprint.

    Medicine & Life Sciences